Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abate, alleviate, Allure, aspect, back, Brain, breakthrough, buildup, callable, CelleRxfor, clarifying, constraint, Dakota, decolonization, DGCL, domiciled, driven, eleven, eleventh, Emery, EmeryStation, exert, eyecare, floor, Geckler, grew, higher, IHT, intolerance, invoice, invoiced, KBSIII, Landlord, LASIK, left, load, multicenter, multitude, noncash, older, overhead, pattern, poised, Powell, pre, predominantly, qualitative, quantitative, recipient, referenced, released, remediated, remediation, rentable, rental, repaid, repayment, Rider, sequential, shard, sixteen, sixtieth, Soldincreased, standby, Station, strike, sublease, subleasing, subsection, technical, thirteenth, today, unified, unilaterally, unusable, unusually, unwanted, Willow
Removed:
academic, acne, addressing, administered, administration, advantage, alliance, announcement, assist, attract, BAYnovation, biofilm, candidate, capture, Center, challenging, clear, collaborate, collaborative, collectively, comply, conducting, continuation, convenience, country, create, dedicated, defer, dilution, diminished, distributing, diversification, downturn, Eastern, economy, effort, elimination, endpoint, enforcing, escalate, fast, favorable, formulary, formulating, funded, gained, Galderma, generating, impetigo, initiated, institutional, intense, issuing, justify, kill, killing, launching, natural, negatively, nomenclature, obtaining, optimized, partial, pharmacoeconomic, point, preclinical, priced, profile, prosecuting, protocol, Ramin, rapidly, realize, regain, reissued, relinquish, render, replaced, repurchased, restrict, SFDA, South, submitted, succeed, Taiwan, targeted, therapeutic, tolerated, treated, uncompetitive, viral, withholding
Filing tables
Filing exhibits
NBY similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consentto the incorporation by reference in Registration Statements on Form S-8 (File Nos. 333-215680, 333-211754, 333-208985, 333-203109, 333-196764, 333-194383, 333-185998, 333-180461, 333-171981, 333-147334, 333-157041, and 333-164469) and Form S-3 (File Nos. 333-211944, 333-211943 333-204998, 333-203735, 333-203112, 333-159917 and 333-180460) of NovaBay Pharmaceuticals, Inc. of our reportdated March 23, 2017, relating to the consolidated financial statements of NovaBay Pharmaceuticals, Inc., which appears in this Annual Report on Form 10-K.
/s/ OUM & CO. LLP
San Francisco, California
March 23, 2017